RT Journal Article
SR Electronic
T1 Results reporting for clinical trials led by medical universities and university hospitals in the Nordic countries was often missing or delayed
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.02.04.24301363
DO 10.1101/2024.02.04.24301363
A1 Nilsonne, Gustav
A1 Wieschowski, Susanne
A1 DeVito, Nicholas J.
A1 Salholz-Hillel, Maia
A1 Bruckner, Till
A1 Klas, Katarzyna
A1 Suljic, Tarik
A1 Yerunkar, Samruddhi
A1 Olsson, Natasha
A1 Cruz, Carolina
A1 Strzebonska, Karolina
A1 Småbrekke, Lars
A1 Wasylewski, Mateusz T.
A1 Bengtsson, Johan
A1 Ringsten, Martin
A1 Schuster, Aminul
A1 Krawczyk, Tomasz
A1 Paraskevas, Themistoklis
A1 Ahnström, Love
A1 Raittio, Eero
A1 Herczeg, Luca
A1 Hesselberg, Jan-Ole
A1 Karlsson, Sofia
A1 Borana, Ronak
A1 Bruschettini, Matteo
A1 Mulinari, Shai
A1 Lizárraga, Karely
A1 Siebert, Maximilian
A1 Hildebrand, Nicole
A1 Ramakrishnan, Shreya
A1 Janiaud, Perrine
A1 Zavalis, Emmanuel
A1 Franzen, Delwen
A1 Boesen, Kim
A1 Hemkens, Lars G.
A1 Naudet, Florian
A1 Possmark, Sofie
A1 Willén, Rebecca M.
A1 Ioannidis, John P.
A1 Strech, Daniel
A1 Axfors, Cathrine
YR 2024
UL http://medrxiv.org/content/early/2024/02/05/2024.02.04.24301363.abstract
AB Objective To systematically evaluate timely reporting of clinical trial results at medical universities and university hospitals in the Nordic countries.Study Design and Setting In this cross-sectional study, we included trials (regardless of intervention) registered in the EU Clinical Trials Registry and/or ClinicalTrials.gov, completed 2016-2019, and led by a university with medical faculty or university hospital in Denmark, Finland, Iceland, Norway, or Sweden. We identified summary results posted at the trial registries, and conducted systematic manual searches for results publications (e.g., journal articles, preprints). We present proportions with 95% confidence intervals (CI), and medians with interquartile range (IQR). Protocol: https://osf.io/wua3rResults Among 2,113 included clinical trials, 1,638 (77.5%, 95%CI 75.9-79.2%) reported any results during our follow-up; 1,092 (51.7%, 95%CI 49.5-53.8%) reported any results within 2 years of the global completion date; and 42 (2%, 95%CI 1.5-2.7%) posted summary results in the registry within 1 year. Median time from global completion date to results reporting was 698 days (IQR 1,123). 856/1,681 (50.9%) of ClinicalTrials.gov-registrations were prospective. Denmark contributed approximately half of all trials. Reporting performance varied widely between institutions.Conclusion Missing and delayed results reporting of academically-led clinical trials is a pervasive problem in the Nordic countries. We relied on trial registry information, which can be incomplete. Institutions, funders, and policy makers need to support trial teams, ensure regulation adherence, and secure trial reporting before results are permanently lost.What is new?- Many Nordic registered clinical trials were reported late or not at all.- Almost one in four trials remained unreported at the end of our search period.- About half of registered trials had reported results two years after completion.- Only 2% of trials posted summary results in the registry one year after completion.- Concerted action is needed to improve reporting of Nordic clinical trials.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://osf.io/wua3r Funding StatementCA reports funding for this project by the Knut and Alice Wallenberg Foundation through the Wallenberg Foundation Postdoctoral Scholarship Program at Stanford (KAW 2019.0561). The complete funding statement is available in the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data on clinical trials were collected from publicly available databases: https://clinicaltrials.gov/ and https://eudract.ema.europa.eu/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced are available online at https://zenodo.org/records/10091147 All code used for data processing available online at https://github.com/cathrineaxfors/nordic-trial-reportinghttps://zenodo.org/records/10091147https://github.com/cathrineaxfors/nordic-trial-reporting